TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Infectious Disease
Division of General Internal Medicine
National Taiwan University Hospital Yunlin Branch
Division of General Internal Medicine
更新時間：2023-09-19
洪健清HUNG, CHIEN-CHING
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
85Publications
11
Hsu YY, Wu D, Hung CC, Huang SS, Yuan FH, Lee MH, Huang CT, Shie SS, Huang PY, Yang CC, Cheng CW, Leu HS, Wu TS, Huang YC. Methicillin-resistant Staphylococcus aureus nasal colonization among HIV-infected patients in Taiwan: prevalence, molecular characteristics and associated factors with nasal carriage. BMC Infect Dis. 2020 Mar 30;20(1):254. doi: 10.1186/s12879-020-04979-8. PMID: 32228480; PMCID: PMC7106609.
12
Kuo PH, Sun HY, Chuang YC, Wu PY, Liu WC, Hung CC. Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide. Int J Infect Dis. 2020 Mar;92:71-77. doi: 10.1016/j.ijid.2019.12.029. Epub 2019 Dec 26. PMID: 31884172.
13
Yu ZY, Tsai MJ, Lin YJ, Liu WD, Chou SC, Hung CC. Disseminated gonococcal infection in a patient with paroxysmal nocturnal hemoglobinuria having received ravulizumab and meningococcal vaccine. J Microbiol Immunol Infect. 2020 Aug;53(4):660-662. doi: 10.1016/j.jmii.2020.06.013. Epub 2020 Jun 30. PMID: 32624359.
14
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man CY, Urbaityte R, Brandon DJ, Underwood M, Tenorio AR, Pappa KA, Wynne B, Gartland M, Aboud M, van Wyk J, Smith KY. Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials. J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):310-318. doi: 10.1097/QAI.0000000000002275. Erratum in: J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):e21. PMID: 31834000; PMCID: PMC7043729.
15
Huang SH, Tsai MS, Lee CY, Tsai CS, Liu CE, Lee YT, Chen HA, Chen LY, Lu YM, Tsai WC, Hsu WT, Liu WD, Yang CJ, Sun HY, Ko WC, Lu PL, Hung CC; Taiwan HIV Study Group. Ongoing transmission of Entamoeba histolytica among newly diagnosed people living with HIV in Taiwan, 2009-2018. PLoS Negl Trop Dis. 2020 Jun 12;14(6):e0008400. doi: 10.1371/journal.pntd.0008400. PMID: 32530918; PMCID: PMC7314233.
16
Huang SH, Lin SW, Chang SY, Lin YT, Sun HY, Liu WC, Su YC, Hung CC, Chang SC. Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study. J Microbiol Immunol Infect. 2020 Feb;53(1):60-68. doi: 10.1016/j.jmii.2018.05.001. Epub 2018 May 29. PMID: 29884449.
17
Chen GJ, Lee YL, Lee CH, Sun HY, Cheng CY, Tsai HC, Huang SH, Lee YC, Hsieh MH, Chang SY, Chuang YC, Su LS, Chang SF, Tang HJ, Hung CC; Taiwan HIV Study Group. Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV. J Antimicrob Chemother. 2020 Oct 1;75(10):2986-2993. doi: 10.1093/jac/dkaa287. PMID: 32737511.
18
Liu WD, Chang SY, Wang JT, Tsai MJ, Hung CC, Hsu CL, Chang SC. Prolonged virus shedding even after seroconversion in a patient with COVID-19. J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.063. Epub 2020 Apr 10. PMID: 32283147; PMCID: PMC7151379.
19
Eron J, Hung CC, Baril JG, Slim J, Falcó V, Bogner J, Maggiolo F, Mills A, Sievers J, Man CY, Urbaityte R, Underwood M, Tenorio AR, Pappa KA, Wynne B, Koteff J, Gartland M, Smith KY, Aboud M. Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis. J Acquir Immune Defic Syndr. 2020 May 1;84(1):60-65. doi: 10.1097/QAI.0000000000002302. PMID: 31977595.
20
Lin KY, Lee YL, Huang SH, Chen GJ, Hung CC. Public Health Intervention Strategies to Contain Hepatitis A Outbreaks. Clin Infect Dis. 2020 Jul 27;71(3):697. doi: 10.1093/cid/ciz1002. PMID: 31608407.
